1141471-99-9

Basic information

• Product Name: 4-{5-[4-(2-methylpiperidin-1-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl}benzenesulfonamide
• Synonyms: 4-{5-[4-(2-methylpiperidin-1-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl}benzenesulfonamide
• CAS NO: 1141471-99-9
• Molecular Weight: 466.484
• Mol File: 1141471-99-9.mol

Chemical Properties

• CAS DataBase Reference: 4-{5-[4-(2-methylpiperidin-1-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl}benzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{5-[4-(2-methylpiperidin-1-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl}benzenesulfonamide(1141471-99-9)
• EPA Substance Registry System: 4-{5-[4-(2-methylpiperidin-1-yl)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl}benzenesulfonamide(1141471-99-9)

Safety Data

• Hazardous Substances Data: 1141471-99-9(Hazardous Substances Data)

Upstream product

• 1140461-91-1 4-(2-methylpiperidin-1-yl)-3-(trifluoromethyl)benzoic acid 
• 4476-10-2 N'-hydroxy-4-sulfamoylbenzimidamide 

Relevant articles and documents

OXADIAZOLE DERIVATIVES

The invention relates to compounds of formula (I): wherein R1, R2, Ra, Rb, W, Q and S have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.